HEPA(Delisted)
Hepion·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 0
Bearish signal 2
Price Hits New Low
Price Hits 52-week Low
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About HEPA
Hepion Pharmaceuticals, Inc.
A biopharmaceutical company that developing multipotent drug therapies for the treatment of chronic liver disease
55 Madison Ave, Suite 400- PMB# 4362, Morristown, New Jersey 07960
--
Hepion Pharmaceuticals, Inc., was incorporated under the laws of the State of Delaware on May 15, 2013. The company is a biopharmaceutical company headquartered in Edison, New Jersey, focused on the development of drug therapies for the treatment of chronic fibrosis-related diseases. The main therapeutic approaches specifically address the disease mechanisms associated with fibrosis and inflammation and show potential for the treatment of non-alcoholic steatohepatitis, hepatocellular carcinoma, viral hepatitis and other fibrotic diseases.
Company Financials
EPS
HEPA has released its 2023 Q3 earnings. EPS was reported at -2.74, versus the expected -3.12, beating expectations. The chart below visualizes how HEPA has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
